- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0022697

Mekong Pharmaceuticals Private Limited
About Mekong Pharmaceuticals Private Limited
Data last updated:
Mekong Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC125052. Its GSTIN is 36AALCM9049H1ZZ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maheshwar Suryapet and Suryapet Sarika.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 6 – 93/D Plot No. 1697 – 1698 Flat No. 203 Nirvana Asset 3rd Layout Pragathinagar, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2023, the company reported a revenue of ₹29.99 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹17.84 Lakh (net margin 0.6%) and EBITDA of -₹72.9 Lakh (EBITDA margin -2.4%). Revenue has grown at a compounded annual rate (CAGR) of 128% over three years.
As per MCA filings, the company has open charges of ₹1.89 Cr on record. Court records list 16 cases involving the company, including 1 filed by the company and 15 filed against it; 10 cases are pending.
Mekong Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0022697).
Company details
Recognitions & Rankings of Mekong Pharmaceuticals
Contact details
Mekong Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6 – 93/D Plot No. 1697 – 1698 Flat No. 203 Nirvana Asset 3rd Layout Pragathinagar, Hyderabad, Telangana, India – 500090
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Mekong Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mekong Pharmaceuticals Private Limited
FY 2024 filings availableMekong Pharmaceuticals Private Limited reported revenue of ₹29.99 Cr (down 11% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 128%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹29.99 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹72.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.4% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mekong Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mekong Pharmaceuticals Private Limited
Mekong Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maheshwar Suryapet Also directs: Greenovel Life Sciences Private Limited | Director | 12 Jun 2018 | 8 Years 5 Months | Current |
| Suryapet Sarika | Director | 12 Jun 2018 | 8 Years 5 Months | Current |
Auditor
Mekong Pharmaceuticals Private Limited is audited by J RAGHURAM & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J RAGHURAM & CO | FY 2023 | 017642S |
Shareholding
The shareholding of Mekong Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mekong Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2021 | 100492895 | Axis Bank Limited | ₹10.03 Lakh | Open | |
| 17 Dec 2020 | 100401027 | Canara Bank | ₹1.79 Cr | Open |
To see the full charge records of Mekong Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Mekong Pharmaceuticals Private Limited has 16 court cases on record: 1 filed by Mekong Pharmaceuticals, 15 filed against it. 10 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 15 | 9 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by Aditya Birla Finance Ltd Rep by Dudekula Shareef | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed against the company by K Rasiklal Exim Pvt Ltd Through Mr Rushin Harshad Modi | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Ltd. | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against The Union of India | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Fedbank Financial Services | Pending |
To see the full case history of Mekong Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mekong Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mekong Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AALCM9049H1ZZ | Telangana | Active | 24 Jul 2018 |
To see the full GST registrations and return filing status of Mekong Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mekong Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Maheshwar Suryapet was appointed as Director on 12 Jun 2018.
Frequently asked questions
Mekong Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2018 (8+ years old) and is registered under CIN U74999TG2018PTC125052.
Mekong Pharmaceuticals has 2 current directors:
- Maheshwar Suryapet - Director
- Suryapet Sarika - Director
The latest financial statements of Mekong Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Mekong Pharmaceuticals is 36AALCM9049H1ZZ, registered in Telangana.
The CIN (Corporate Identification Number) of Mekong Pharmaceuticals is U74999TG2018PTC125052. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mekong Pharmaceuticals has 16 court cases on record: 1 filed by the company and 15 filed against it. 10 are pending. Most are in the district courts.
Mekong Pharmaceuticals was incorporated on 12 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Maheshwar Suryapet was appointed as Director on 12 Jun 2018. Suryapet Sarika was appointed as Director on 12 Jun 2018.
Yes, Mekong Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0022697).
The registered office of Mekong Pharmaceuticals is at 6 – 93D Plot No. 1697 – 1698 Flat No. 203 Nirvana Asset 3rd Layout Pragathinagar, Hyderabad, Telangana, India – 500090.

